The shape-shifting telehealth company has spent the past year trying to cash in on GLP-1s, the hottest drug to hit weight loss in decades. It could all slip away. By Madison Muller and Devin Leonard

How Eli Lilly Got Huge by Making Us Thin
31:22

Cyberbullying Group 764 Torments Teenagers as Blood Sport
28:19

Caveat Injector
36:42